Veracyte (VCYT) Tops Q2 EPS by 33c, provides guidance

Veracyte (NASDAQ: VCYT) reported Q2 EPS of $0.44, $0.33 better than the analyst estimate of $0.11. Revenue for the quarter came in at $130.16 million versus the consensus estimate of $121.1 million.

GUIDANCE:

Veracyte sees FY2025 revenue of $496-504 million, versus the consensus of $491.9 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Cytek faces $56M damages award in Beckman Coulter patent case